hodgkin lymphoma

Showing 26 - 50 of 232

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

Recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • Denver, Colorado
  • +3 more
Jan 10, 2023

Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

Completed
  • Multiple Myeloma
  • +11 more
  • Pre-biotic foods/drinks
  • Charlottesville, Virginia
    University of Virginia
Jan 2, 2023

Circulating Tumor DNA Genotyping for Biological Monitoring of

Active, not recruiting
  • Hodgkin Lymphoma
    • Avellino, Italy
    • +12 more
    Dec 22, 2022

    Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

    Active, not recruiting
    • Multiple Myeloma
    • +4 more
    • Total Body Irradiation
    • +5 more
    • Los Angeles, California
      Cedars Sinai Medical Center
    Dec 21, 2022

    Hodgkin Lymphoma, Adolescent Behavior, Chemo Effect Trial (Description of therapeutical results)

    Not yet recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Description of therapeutical results
    • (no location specified)
    Dec 15, 2022

    Hodgkin Lymphoma Trial in Italy (Doxorubicin, Bleomycin, Vinblastine)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Alessandria, Italy
    • +45 more
    Dec 22, 2022

    Hodgkin Lymphoma Trial in Moscow (Nivolumab)

    Recruiting
    • Hodgkin Lymphoma
    • Moscow, Russian Federation
      National Research Center for Hematology
    Dec 13, 2022

    Solid Tumor, Adult, Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in India (AUR105)

    Recruiting
    • Solid Tumor, Adult
    • +2 more
    • Vadodara, Gujarat, India
    • +6 more
    Dec 14, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

    Recruiting
    • Cancer
    • +21 more
    • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Dec 7, 2022

    Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (brentuximab vedotin)

    Terminated
    • Hodgkin Lymphoma
    • +2 more
    • brentuximab vedotin
    • Anaheim, California
    • +18 more
    Dec 6, 2022

    ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)

    Not yet recruiting
    • ALL
    • +3 more
    • Transcranial photobiomodulation (tPBM) - Mobile System
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Dec 6, 2022

    Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)

    Active, not recruiting
    • Hodgkin Lymphoma
    • brentuximab vedotin
    • +5 more
    • Fountain Valley, California
    • +75 more
    Dec 2, 2022

    Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

    Withdrawn
    • Hodgkin Lymphoma
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Nov 28, 2022

    Hodgkin Lymphoma Trial (Tislelizumab, AVD, Radiotherapy)

    Not yet recruiting
    • Hodgkin Lymphoma
    • Tislelizumab, AVD, Radiotherapy
    • (no location specified)
    Nov 15, 2022

    Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

    Recruiting
    • Mantle Cell Lymphoma
    • +9 more
    • L-Bcl-2 antisense oligonucleotide
    • Augusta, Georgia
    • +2 more
    Nov 18, 2022

    Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

    Active, not recruiting
    • Acute Leukemia
    • +14 more
    • Duarte, California
      City of Hope Medical Center
    Nov 18, 2022

    Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 7, 2022

    Hodgkin Lymphoma Trial in Australia, New Zealand (pembrolizumab)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Concord, New South Wales, Australia
    • +5 more
    Nov 3, 2022

    Hodgkin Lymphoma Trial in Moscow (Nivolumab)

    Recruiting
    • Hodgkin Lymphoma
    • Moscow, Russian Federation
      The Federal Budget-Funded Institution National Medical Surgical
    Oct 31, 2022

    Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

    Recruiting
    • Acute Leukemia
    • +18 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 26, 2022

    Hodgkin Lymphoma Trial in France (blood samples)

    Active, not recruiting
    • Hodgkin Lymphoma
    • blood samples
    • Angers, France
    • +21 more
    Oct 27, 2022

    Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

    Recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Brentuximab Vedotin 50 MG [Adcetris]
    • Leon, Guanajuato, Mexico
      Hospital Regional Alta Especialidad Bajio
    Oct 24, 2022

    Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Brentuximab Vedotin
    • +2 more
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022